00:00The first IPO which I want to know is Enlon Healthcare IPO, the subscription date is 26 August
00:06and the 29th is coming to the next year. The price range is 86 rupees to 91 rupees.
00:13Lot size is 144 share, issue size is 121 crore. Minimum investment is 14924 rupees
00:24and the GMP rate is 5 rupees. The total stock of the IPO is 75% of the QIB and the 15% of the NII and the Retail Investors
00:39is 10% of the shares. Now, I want to know what you have to know about this IPO,
00:47what you have to know, what you need to know, what you need to know, what you need to know,
00:52what you need to know, what you need to know, what you need to know, what you need to know and what you need to know.
00:56Good afternoon, Pragati. If I talk to Enlon Healthcare company, this company is a chemical manufacturing company
01:06and this company is a high priority, advanced pharmaceutical, intermediate.
01:12Its main product is Exoprofen Sodium Dehydride.
01:18So which product is what it is, which we need to know, pain or inflammation to our health needs to know
01:24that other benefits come to treatment. So this company is basically a chemical manufacturing company
01:32and it also goes to pharmaceutical companies and other companies, there are personal care
01:38So, personal care, FMCG, and if I talk about this company about financials, I think the performance of the financial performance is good.
01:46And the price, which we are bringing, is 86 to 91,
01:51So, the pricing that we have done in the 91,
01:54was very reasonable and not left a lot of investors on the table.
02:00So, all of our analysis, all of our analysis, which we have found,
02:06we can subscribe to our channel.
02:11We have a small listing gain.
02:13We don't have a big listing gain.
02:15And if we have a long term, if we have a long term, we can put it.
02:19So, the price here is only a limited listing gain and long term.
02:26So, if you want to apply to this IPO, you can put money in this IPO.
02:30So, if you want to apply to this IPO,
02:35then you have to keep your attention.
02:37The company's finances are okay.
02:39As you said in your research.
02:41But the thing is that if you have a listing gain,
02:45then you will get a limited gain.
02:48But long term, the company will be profitable.
02:52You can get a good return.
Comments